Latest Ratings for CMS Date Firm Action From To Mar 2022 BMO Capital Maintains Outperform Mar 2022 Mizuho Maintains Buy Jan 2022 Keybanc Maintains Overweight View More Analyst Ratings for CMS View the Latest Analyst Ratings read more ​Â
Latest Ratings for EMN Date Firm Action From To Mar 2022 Piper Sandler Maintains Neutral Jan 2022 Barclays Maintains Equal-Weight Jan 2022 Morgan Stanley Maintains Overweight View More Analyst Ratings for EMN View the Latest Analyst Ratings read more ​Â
Latest Ratings for MBUU Date Firm Action From To Feb 2022 Raymond James Maintains Outperform Jan 2022 Truist Securities Maintains Buy Nov 2021 Raymond James Maintains Outperform View More Analyst Ratings for MBUU View the Latest Analyst Ratings read more ​Â
Latest Ratings for AFL Date Firm Action From To Feb 2022 Morgan Stanley Maintains Overweight Feb 2022 Raymond James Maintains Outperform Jan 2022 Wolfe Research Initiates Coverage On Peer Perform View More Analyst Ratings for AFL View the Latest Analyst Ratings read more ​Â
Latest Ratings for VIAV Date Firm Action From To Aug 2021 Morgan Stanley Maintains Equal-Weight Jul 2021 JP Morgan Downgrades Overweight Neutral Jul 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for VIAV View the Latest Analyst Ratings read more ​Â
Latest Ratings for AGIO Date Firm Action From To Mar 2022 Goldman Sachs Maintains Sell Mar 2022 HC Wainwright & Co. Maintains Buy Feb 2022 RBC Capital Maintains Outperform View More Analyst Ratings for AGIO View the Latest Analyst Ratings read more ​Â
Latest Ratings for SUM Date Firm Action From To Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Barclays Maintains Equal-Weight Dec 2021 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for SUM View the Latest Analyst Ratings read more ​Â
Aptos’s (CRYPTO: APT) price has decreased 3.11% over the past 24 hours to $8.9, continuing its downward trend over the past week of -5.0%, moving from $9.39 to its current price. read more ​Â
This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.
